Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965291261> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W1965291261 endingPage "273" @default.
- W1965291261 startingPage "269" @default.
- W1965291261 abstract "This study compares the effects of cholestyramine (16 g/d) and pravastatin (40 mg/d) on lipoprotein particles defined by their apolipoprotein composition (Lp A-I, Lp A-II:A-I, Lp E:B, and Lp C-III:B). Analysis was performed after 4, 8, and 12 weeks of therapy. Low-density lipoprotein (LDL) cholesterol decreased by 25.1% to 35.0% with cholestyramine and 26.2% to 30.7% with pravastatin, while triglycerides decreased slightly with pravastatin therapy and increased slightly during cholestyramine administration. The fall in cholesterol was mainly due to a decrease in very-low-density lipoprotein (VLDL) and LDL cholesterol; high-density lipoprotein (HDL) cholesterol increased. Apolipoprotein B was reduced dramatically (by 21.7% to 30.5% with cholestyramine and 27.7% to 37.4% with pravastatin). No significant effect on apolipoproteins C-III and E was observed with cholestyramine, while pravastatin reduced these parameters slightly. Apolipoprotein A-I increased during therapy with both drugs, while apolipoprotein A-II was slightly decreased. Although the drugs had nearly the same effects on plasma lipids, their influence on lipoprotein particles defined by their apolipoprotein composition was substantially different. Lp A-II:A-I was increased by both drugs (+8.1% to +41.2% for cholestyramine and +7.2% to +32.6% for pravastatin). Lp A-I was also increased with both drugs, but cholestyramine had a more constant and pronounced effect than pravastatin (+15.1% to +21.7% for cholestyramine and +1.7% to +13.0% for pravastatin). Lp E:B and Lp C-III:B were consistently decreased by pravastatin (-10.2% to -36.5% for LP E:B and -7.2% to -20.9% for Lp C-III:B), while cholestyramine had variable effects on these particles.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W1965291261 created "2016-06-24" @default.
- W1965291261 creator A5012214212 @default.
- W1965291261 creator A5045448492 @default.
- W1965291261 creator A5051580102 @default.
- W1965291261 creator A5070967424 @default.
- W1965291261 date "1990-03-01" @default.
- W1965291261 modified "2023-10-07" @default.
- W1965291261 title "Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition" @default.
- W1965291261 cites W127752689 @default.
- W1965291261 cites W1488147530 @default.
- W1965291261 cites W1832709945 @default.
- W1965291261 cites W1989432650 @default.
- W1965291261 cites W2042385191 @default.
- W1965291261 cites W2051792271 @default.
- W1965291261 cites W2059931409 @default.
- W1965291261 cites W2105677861 @default.
- W1965291261 cites W2136245314 @default.
- W1965291261 cites W2145512527 @default.
- W1965291261 cites W2157971481 @default.
- W1965291261 cites W2271378708 @default.
- W1965291261 cites W2341665659 @default.
- W1965291261 cites W4230285830 @default.
- W1965291261 cites W4301955712 @default.
- W1965291261 doi "https://doi.org/10.1016/0026-0495(90)90046-f" @default.
- W1965291261 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2106607" @default.
- W1965291261 hasPublicationYear "1990" @default.
- W1965291261 type Work @default.
- W1965291261 sameAs 1965291261 @default.
- W1965291261 citedByCount "51" @default.
- W1965291261 countsByYear W19652912612016 @default.
- W1965291261 countsByYear W19652912612020 @default.
- W1965291261 countsByYear W19652912612021 @default.
- W1965291261 crossrefType "journal-article" @default.
- W1965291261 hasAuthorship W1965291261A5012214212 @default.
- W1965291261 hasAuthorship W1965291261A5045448492 @default.
- W1965291261 hasAuthorship W1965291261A5051580102 @default.
- W1965291261 hasAuthorship W1965291261A5070967424 @default.
- W1965291261 hasConcept C126322002 @default.
- W1965291261 hasConcept C134018914 @default.
- W1965291261 hasConcept C185592680 @default.
- W1965291261 hasConcept C2778163477 @default.
- W1965291261 hasConcept C2778697171 @default.
- W1965291261 hasConcept C2779519902 @default.
- W1965291261 hasConcept C2780072125 @default.
- W1965291261 hasConcept C55493867 @default.
- W1965291261 hasConcept C62746215 @default.
- W1965291261 hasConcept C71924100 @default.
- W1965291261 hasConcept C8243546 @default.
- W1965291261 hasConceptScore W1965291261C126322002 @default.
- W1965291261 hasConceptScore W1965291261C134018914 @default.
- W1965291261 hasConceptScore W1965291261C185592680 @default.
- W1965291261 hasConceptScore W1965291261C2778163477 @default.
- W1965291261 hasConceptScore W1965291261C2778697171 @default.
- W1965291261 hasConceptScore W1965291261C2779519902 @default.
- W1965291261 hasConceptScore W1965291261C2780072125 @default.
- W1965291261 hasConceptScore W1965291261C55493867 @default.
- W1965291261 hasConceptScore W1965291261C62746215 @default.
- W1965291261 hasConceptScore W1965291261C71924100 @default.
- W1965291261 hasConceptScore W1965291261C8243546 @default.
- W1965291261 hasIssue "3" @default.
- W1965291261 hasLocation W19652912611 @default.
- W1965291261 hasLocation W19652912612 @default.
- W1965291261 hasOpenAccess W1965291261 @default.
- W1965291261 hasPrimaryLocation W19652912611 @default.
- W1965291261 hasRelatedWork W2028276670 @default.
- W1965291261 hasRelatedWork W2039772954 @default.
- W1965291261 hasRelatedWork W2043823780 @default.
- W1965291261 hasRelatedWork W205211558 @default.
- W1965291261 hasRelatedWork W2060779185 @default.
- W1965291261 hasRelatedWork W2065643785 @default.
- W1965291261 hasRelatedWork W2287351208 @default.
- W1965291261 hasRelatedWork W4236151920 @default.
- W1965291261 hasRelatedWork W4244879946 @default.
- W1965291261 hasRelatedWork W61180247 @default.
- W1965291261 hasVolume "39" @default.
- W1965291261 isParatext "false" @default.
- W1965291261 isRetracted "false" @default.
- W1965291261 magId "1965291261" @default.
- W1965291261 workType "article" @default.